These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10430621)

  • 21. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.
    Brieger A; Trojan J; Raedle J; Plotz G; Zeuzem S
    Gut; 2002 Nov; 51(5):677-84. PubMed ID: 12377806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defects of DNA mismatch repair in human prostate cancer.
    Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW
    Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mismatch repair proteins MSH2, MLH1, and EXO1 are important for class-switch recombination events occurring in B cells that lack nonhomologous end joining.
    Eccleston J; Yan C; Yuan K; Alt FW; Selsing E
    J Immunol; 2011 Feb; 186(4):2336-43. PubMed ID: 21242524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Class switch recombination efficiency and junction microhomology patterns in Msh2-, Mlh1-, and Exo1-deficient mice depend on the presence of mu switch region tandem repeats.
    Eccleston J; Schrader CE; Yuan K; Stavnezer J; Selsing E
    J Immunol; 2009 Jul; 183(2):1222-8. PubMed ID: 19553545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ig isotype switching in B lymphocytes. Isolation and characterization of clonal variants of the murine Ly-1+ B cell lymphoma, CH12, expressing isotypes other than IgM.
    Arnold LW; Grdina TA; Whitmore AC; Haughton G
    J Immunol; 1988 Jun; 140(12):4355-63. PubMed ID: 3131432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin class switch recombination is impaired in Atm-deficient mice.
    Lumsden JM; McCarty T; Petiniot LK; Shen R; Barlow C; Wynn TA; Morse HC; Gearhart PJ; Wynshaw-Boris A; Max EE; Hodes RJ
    J Exp Med; 2004 Nov; 200(9):1111-21. PubMed ID: 15504820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation.
    Ehrenstein MR; Neuberger MS
    EMBO J; 1999 Jun; 18(12):3484-90. PubMed ID: 10369687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated mutant frequencies and increased C : G-->T : A transitions in Mlh1-/- versus Pms2-/- murine small intestinal epithelial cells.
    Baross-Francis A; Makhani N; Liskay RM; Jirik FR
    Oncogene; 2001 Feb; 20(5):619-25. PubMed ID: 11313994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dimerization of MLH1 and PMS2 limits nuclear localization of MutLalpha.
    Wu X; Platt JL; Cascalho M
    Mol Cell Biol; 2003 May; 23(9):3320-8. PubMed ID: 12697830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biallelic somatic inactivation of the mismatch repair gene MLH1 in a primary skin melanoma.
    Castiglia D; Pagani E; Alvino E; Vernole P; Marra G; Cannavò E; Jiricny J; Zambruno G; D'Atri S
    Genes Chromosomes Cancer; 2003 Jun; 37(2):165-75. PubMed ID: 12696065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination.
    Ehrenstein MR; Rada C; Jones AM; Milstein C; Neuberger MS
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14553-8. PubMed ID: 11717399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2.
    Cannavo E; Gerrits B; Marra G; Schlapbach R; Jiricny J
    J Biol Chem; 2007 Feb; 282(5):2976-86. PubMed ID: 17148452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visualization of mosaicism in tissues of normal and mismatch-repair-deficient mice carrying a microsatellite-containing transgene.
    Hersh MN; Stambrook PJ; Stringer JR
    Mutat Res; 2002 Aug; 505(1-2):51-62. PubMed ID: 12175905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.
    Buchanan DD; Tan YY; Walsh MD; Clendenning M; Metcalf AM; Ferguson K; Arnold ST; Thompson BA; Lose FA; Parsons MT; Walters RJ; Pearson SA; Cummings M; Oehler MK; Blomfield PB; Quinn MA; Kirk JA; Stewart CJ; Obermair A; Young JP; Webb PM; Spurdle AB
    J Clin Oncol; 2014 Jan; 32(2):90-100. PubMed ID: 24323032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of DNA-mismatch repair gene expression in oral melanomas.
    Korabiowska M; Brinck U; Ruschenburg I; Honig JF; Stachura J; Droese M
    Oncol Rep; 1999; 6(4):921-3. PubMed ID: 10373682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
    Nakagawa H; Lockman JC; Frankel WL; Hampel H; Steenblock K; Burgart LJ; Thibodeau SN; de la Chapelle A
    Cancer Res; 2004 Jul; 64(14):4721-7. PubMed ID: 15256438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA mismatch repair enzyme activity and gene expression in prostate cancer.
    Yeh CC; Lee C; Dahiya R
    Biochem Biophys Res Commun; 2001 Jul; 285(2):409-13. PubMed ID: 11444857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postreplicative mismatch repair factors are recruited to Epstein-Barr virus replication compartments.
    Daikoku T; Kudoh A; Sugaya Y; Iwahori S; Shirata N; Isomura H; Tsurumi T
    J Biol Chem; 2006 Apr; 281(16):11422-30. PubMed ID: 16510450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
    Jessup CJ; Redston M; Tilton E; Reimann JD
    Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.